Executive record
Matthew Gall
Matthew Gall signed Kalaris Therapeutics, Inc.'s 10-K as Chief Financial Officer (Principal Financial Officer), filed March 17, 2026.
1 verified record · 1 company
Career line from the records
1Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.
2026-03-1710-K signatureKalaris Therapeutics, Inc.
Signed the annual report as Chief Financial Officer (Principal Financial Officer)
10-K filed March 17, 2026 · sec.gov
Companies
1This page lists only verified filing records that name Matthew Gall, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.